Coherent light generators – Particular beam control device – Mode locking
Patent
1988-09-30
1990-09-04
Gonzalez, Frank
Coherent light generators
Particular beam control device
Mode locking
372 53, 372 30, 372 32, 372 94, 372 97, H01S 3098
Patent
active
049550276
DESCRIPTION:
BRIEF SUMMARY
TECHNICAL FIELD
This invention relates to a wavelength locked pulsed dye laser system and a method of operating a pulsed dye laser system to provide a wavelength locked pulsed laser light.
BACKGROUND ART
There are a wide variety of fields which utilise laser light. A particular application is in the treatment of human cancer tumours. It has been established that illumination of tumours previously labelled with suitable photoactive substances (for example, HPD - haematoporphyrin derivative) is an effective method of treating such tumours. The wavelength (colour) of the illumination light must be such that interaction with the photoactive substance occurs while at the same time adequate penetration of the tissue is permitted. In the case of the drug HPD, for example, photoactivity occurs for wavelengths in a narrow band (.+-.5 nm) centred at 630 nm while good transmission of light through haemoglobin and thus through the tissue is obtained for wavelengths greater than 600 nm.
Both continuous and pulsed light have been used for the above purpose. Continuous light sources employed to date have been conventional arc discharge lamps of high intensity used with appropriate filters or a continuous dye laser pumped by an argon ion laser. Pulsed light of the desired wavelength and average power can be obtained using a gold vapour laser, which operates directly within the required band at 628 nm or a pulsed dye laser pumped by a pulsed copper laser and whose wavelength is tuned in the required band. Given that fibre-optics are required to deliver the light to tumour sites within the body, laser sources are preferred over conventional sources (for the puposes of efficient coupling of light into the fibres). Moreover there is evidence that pulsed lasers are superior to continuous lasers in therapeutic effect.
Continuous dye lasers pumped by argon ion lasers have been found to have considerable disadvantages in practice for the above application. These systems are complex requiring delicate alignment which can alter over time and are therefore unreliable for routine use; they are also very expensive to install and maintain and electrically extremely inefficient.
The gold vapour laser, though generating emission directly within the required band at the appropriate energy densities, also has significant disadvantages in practice. The very high operating temperatures, greater than 1750.degree. C., required of the plasma tube place great stress on the construction materials; the low energy conversion efficiency (compared with the copper vapour laser) results in stress on the high-voltage electrical excitation circuitry and components and places added requirements on cooling facilities; and the laser material (gold) is expensive in the quantities required. All these factors combine to make the gold laser also unreliable in operation and expensive to install and maintain.
Pulsed dye lasers based on the pulsed copper laser as a pump source have considerable advantages over both the argon-pumped dye laser and the gold vapour laser. In the first place the copper laser pump source itself is a practical and reliable device (with plasma tube operating temperatures only about 1500.degree. C.), relatively cheap to install and maintain and having good electrical energy conversion efficiency. Second, the efficiency of conversion of the copper laser pump power (at wavelengths in the green and yellow) to high-pulse-rate dye laser output (at wavelengths in the orange, red and infrared) is high, up to 50%, in direct conversion amplifiers. However to achieve such high conversion efficiencies a dye amplifier must be injected with an optical signal at the appropriate wavelength within the amplification band of the dye and with sufficient initial power. Such an injection signal is normally provided by a dye oscillator also optically pumped with a portion of the copper laser pump power. Copper-laser-pumped dye oscillators are themselves relatively inefficient (<15%) in converting the pump laser power to dye oscillator output. The optical
REFERENCES:
patent: 3754195 (1973-08-01), Johnston, Jr. et al.
patent: 3766489 (1973-10-01), Rosenberg et al.
patent: 4019157 (1977-04-01), Hutchinson et al.
patent: 4410995 (1983-10-01), Chiu
patent: 4689794 (1987-08-01), Brosnan
Bradley; "High Power Pulsed Lasers"; Sci. Prog., Oxf.; vol. 57; 1969; pp. 301-322.
Carney et al; "Injection-Locked-Xenon-ion Laser"; IEEE Journal of Quan. Elec., vol. QE-16, No. 1; 01/1980; pp. 9-10.
Yasa et al., "Reciprocal Passive-AR.sup.+ Pump Laser"; Optics Letters, vol. 6, No. 2; 01/1981; pp. 67-69.
Hopkins and Rentzepis, Apl Phys Lett, vol. 47, No. 8, pp. 776 to 778, Oct. 1985.
Ainsworth Mark D.
Piper James A.
Gonzalez Frank
MacQuarie University
LandOfFree
Wavelength locked laser light source does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Wavelength locked laser light source, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Wavelength locked laser light source will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-446993